Related Experiment Video
Updated: Jul 3, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Blood biomarkers in the diagnosis of ischemic stroke: a systematic review
William Whiteley1, Mei-Chiun Tseng, Peter Sandercock
1Division of Clinical Neurosciences, University of Edinburgh, UK. william.whiteley@ed.ac.uk
Insights
Diagnosing ischemic stroke is challenging, with current imaging often insufficient. While numerous blood biomarkers show promise, study limitations prevent clinical recommendation, necessitating improved research standards.
Area of Science:
- Neurology
- Biomarker Discovery
- Diagnostic Accuracy
Background:
- Ischemic stroke diagnosis presents challenges, particularly in early stages or mild cases where CT scans may be normal.
- Magnetic resonance imaging (MRI) is not always feasible for all patients.
- Numerous blood-based biomarkers have been investigated for acute stroke diagnosis.
Purpose of the Study:
- To systematically review the diagnostic literature on blood biomarkers for acute ischemic stroke.
- To assess the utility and limitations of single biomarkers and biomarker panels.
- To provide recommendations for future research in this field.
Main Methods:
- Conducted a systematic review of diagnostic studies on stroke biomarkers.
- Included 21 studies evaluating 58 individual biomarkers and 7 biomarker panels.
- Analyzed study designs, reporting quality, sensitivity, and specificity.
Main Results:
- All evaluated biomarkers demonstrated either high sensitivity or specificity.
- Significant limitations were identified in the design and reporting of all included studies.
- No single biomarker or panel currently meets the criteria for clinical recommendation.
Conclusions:
- Current diagnostic blood biomarkers for ischemic stroke lack sufficient validation for clinical practice.
- Recommendations are proposed for enhancing the design and reporting of future diagnostic biomarker studies.
- Improved research methodology is crucial for establishing reliable blood tests for stroke diagnosis.
Background And Purpose:
The diagnosis of ischemic stroke can be difficult. CT may be normal in the early stages of ischemic stroke or in patients with minor symptoms and MR is not always possible. Many blood markers have been proposed for the diagnosis of stroke in the acute setting.
Methods:
We have systematically reviewed the diagnostic literature and found 21 studies testing 58 single biomarkers and 7 panels of several biomarkers. Although all show either a high sensitivity or specificity, there are limitations in the design and reporting of all the studies that mean no biomarker can be recommended for use in clinical practice.
Conclusions:
We make recommendations for the design and reporting of studies of diagnostic blood biomarkers in stroke.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Acute Coronary Syndrome III: Diagnostic Studies
